Pharmacologic Pitfalls in Heart Failure: A Guide to Drugs that May Cause or Exacerbate Heart Failure. A European Journal of Heart Failure Expert Consensus Document

Drug classes reviewed: antidiabetic agents (e.g. thiazolidinediones, dipeptidyl peptidase-4 inhibitors), antiarrhythmics (particularly Class I and III), calcium channel blockers, NSAIDs, antifungals (e.g. itraconazole, amphotericin B), macrolide antibiotics, antihypertensives (e.g. α1-blockers, centrally acting sympatholytics), neurological and psychiatric medications (e.g. carbamazepine, pregabalin, lithium), selected anaesthetic and anticancer agents (e.g. anthracyclines, VEGF inhibitors)

Individualized therapy, close review of medication regimens and collaborative care to minimize iatrogenic harm